SCHEMBL24976319

SCHEMBL24976319

O=C(O)C1CCN1Cc1cc(Cl)cc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.43
▸ S1PR1 P21453 1/20 0.41
▸ S1PR5 Q9H228 1/20 0.41
▸ CD274 Q9NZQ7 3/20 0.40
▸ PDCD1 Q15116 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PRKG1 Q13976 1/20 0.40
▸ GRM5 P41594 1/20 0.39
▸ MAOA P21397 2/20 0.38
▸ MAOB P27338 2/20 0.38
▸ SIGMAR1 Q99720 2/20 0.38
▸ GRM6 O15303 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ GRN P28799 1/20 0.37
▸ SORT1 Q99523 1/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.37
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7781292 0.91 CYP1A2 (0.50) CD274PDCD1CYP1A2PRKG1SMN1; SMN2
SCHEMBL7781291 0.91 CYP1A2 (0.50) CD274PDCD1CYP1A2PRKG1SMN1; SMN2
SCHEMBL5702015 0.85 S1PR5 (0.46) NOTUMS1PR5CD274PDCD1SIGMAR1
SCHEMBL5701943 0.85 S1PR5 (0.46) NOTUMS1PR5CD274PDCD1SIGMAR1
SCHEMBL2771498 0.81 GRM6 (0.54) S1PR1S1PR5CD274PDCD1CYP1A2
SCHEMBL2771075 0.81 GRM6 (0.54) S1PR1S1PR5CD274PDCD1CYP1A2
SCHEMBL2771071 0.81 GRM6 (0.54) S1PR1S1PR5CD274PDCD1CYP1A2
SCHEMBL3148367 0.77 NPBWR1 (0.53) CD274PDCD1CYP1A2SIGMAR1
SCHEMBL1815987 0.77 NPBWR1 (0.53) CD274PDCD1CYP1A2SIGMAR1
SCHEMBL2030130 0.77 NPBWR1 (0.53) CD274PDCD1CYP1A2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572374-B2 N-cyano-7-azanorbornane derivatives and uses thereof AMGEN INC. (US) 2023-02-07 — — US disclosed
US-11572374-B2 N-cyano-7-azanorbornane derivatives and uses thereof AMGEN INC. (US) 2023-02-07 — — US disclosed
US-20220363694-A1 N-CYANO-7-AZANORBORNANE DERIVATIVES AND USES THEREOF AMGEN INC. (US) 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572374-B2 N-cyano-7-azanorbornane derivatives and uses thereof CYP3A7, CYP51A1, NT5C3B NOTUM 473/4885S1PR1 1269/4885S1PR5 666/4885
US-20220363694-A1 N-CYANO-7-AZANORBORNANE DERIVATIVES AND USES THEREOF CYP3A7, CYP51A1, NT5C3B NOTUM 473/4885S1PR1 1269/4885S1PR5 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback